mifepristone

简明释义

英[mɪˈfeprɪˌstəʊn]美[mɪˈfeprɪˌston]

n. 米非司酮；美服培酮

英英释义

单词用法

同义词

反义词

例句

1.Objective to explore effects of blood platelets and prothrombin time on mifepristone.

目的探讨米非司酮对血小板、血浆凝血酶原时间的影响。

2.Objective to explore the antitumor mechanisms of mifepristone (RU486).

目的探讨米非司酮(RU486)抗肿瘤作用的机制。

3.During a medical abortion, a woman takes oral medications - such as mifepristone (Mifeprex) - in early pregnancy to abort the fetus.

药物堕胎过程中，女性服口服药物-比如米非司酮片-用于孕早期使胎儿流产。

4.Objective To study the effects of mifepristone on proliferation and apoptosis in early pregnant chorionic villi .

目的探讨米非司酮对人早孕绒毛滋养细胞增殖和凋亡的影响。

5.Objective To observe fertility after methotrexate-mifepristone treatment of ectopic pregnancy and to find the factors affecting fertility.

目的观察甲氨喋呤联合米非司酮保守治疗异位妊娠后患者的生育力，探讨对生育力造成影响的因素。

6.Objective to estimate the clinical significance of ultrasonography on before and after anti early pregnancy with mifepristone.

目的评价超声检查米非司酮抗早孕前后临床应用的价值。

7.The doctor prescribed mifepristone for the medical termination of pregnancy.

医生开了米非司酮用于药物终止妊娠。

8.Some women may have questions about the safety of mifepristone during their consultation.

在咨询期间，一些女性可能会对米非司酮的安全性有疑问。

9.After taking mifepristone, patients may experience some cramping.

服用米非司酮后，患者可能会感到一些腹部痉挛。

10.The combination of mifepristone and another medication can enhance its effectiveness.

将米非司酮与另一种药物结合使用可以增强其效果。

11.It is important to follow the doctor's instructions when using mifepristone.

使用米非司酮时，遵循医生的指示非常重要。

作文

In recent years, the discussion surrounding reproductive health has gained significant attention. One key medication that has been at the center of this debate is mifepristone, a drug used in medical abortions. Understanding the implications and uses of mifepristone is crucial for informed discussions about women's health. 米非司酮是一种用于药物流产的药物，它通过阻止孕激素的作用来实现这一目的，从而使子宫内膜无法维持妊娠。 This medication is often used in combination with another drug called misoprostol, which helps to expel the pregnancy from the uterus. The combination of these two medications has proven to be effective and safe for many women seeking to terminate an early pregnancy.The history of mifepristone dates back to the 1980s when it was first developed in France. Since then, it has been approved for use in various countries around the world, including the United States, where it was approved by the FDA in 2000. Despite its approval and the backing of numerous medical organizations, mifepristone remains a contentious topic. Many advocates for women's rights argue that access to mifepristone is essential for reproductive autonomy, while opponents often raise concerns about the ethical implications of abortion.One of the primary benefits of mifepristone is that it allows women to undergo a medical abortion in the privacy of their own homes, which can be less invasive and more comfortable than surgical options. Studies have shown that when taken within the first ten weeks of pregnancy, mifepristone is over 95% effective. This high success rate, combined with the non-invasive nature of the procedure, makes it a popular choice among women who find themselves in difficult situations regarding their pregnancies.However, the availability of mifepristone is not uniform across different regions. In some areas, restrictions on access to this medication can create barriers for women seeking abortions. These restrictions can lead to unsafe practices or force women to travel long distances to obtain care. It is vital for policymakers to consider the impact of such regulations on women's health and well-being.Furthermore, education about mifepristone is essential. Many misconceptions exist about the drug, including its safety and the process involved in a medical abortion. Healthcare providers play a crucial role in dispelling these myths and ensuring that women have accurate information to make informed decisions about their reproductive health.In conclusion, mifepristone represents a significant advancement in reproductive healthcare, providing women with a safe and effective option for terminating early pregnancies. As discussions around reproductive rights continue to evolve, it is essential to ensure that women have access to mifepristone and the necessary support to navigate their choices. By fostering understanding and reducing stigma associated with this medication, society can empower women to take control of their reproductive health and make informed decisions about their bodies. Ultimately, the conversation surrounding mifepristone is not just about a medication; it is about the broader issues of women's rights, healthcare access, and personal autonomy.

近年来，围绕生殖健康的讨论引起了显著关注。其中一个关键药物是米非司酮，它用于药物流产。理解米非司酮的含义和用途对于关于女性健康的知情讨论至关重要。米非司酮是一种用于药物流产的药物，它通过阻止孕激素的作用来实现这一目的，从而使子宫内膜无法维持妊娠。这种药物通常与另一种药物米索前列醇联合使用，后者有助于将妊娠排出子宫。这两种药物的组合在许多寻求终止早期妊娠的女性中被证明是有效且安全的。米非司酮的历史可以追溯到1980年代，当时它在法国首次开发。自那时以来，它已获得多个国家的批准，包括美国，在2000年获得FDA批准。尽管获得了批准并得到了众多医学组织的支持，米非司酮仍然是一个有争议的话题。许多女性权利倡导者认为，获得米非司酮的机会对于生殖自主权至关重要，而反对者则常常提出有关堕胎伦理的担忧。米非司酮的主要好处之一是，它允许女性在自己家中进行药物流产，这可能比外科手术选择更少侵入性且更舒适。研究表明，在怀孕的前十周内服用时，米非司酮的有效性超过95%。这种高成功率，加上程序的非侵入性，使其成为许多面临妊娠困境的女性的热门选择。然而，米非司酮的可获得性在不同地区并不均匀。在某些地区，对这种药物的限制可能会给寻求堕胎的女性造成障碍。这些限制可能导致不安全的做法，或者迫使女性长途旅行以获得护理。政策制定者必须考虑这些规定对女性健康和福祉的影响。此外，关于米非司酮的教育至关重要。关于该药物存在许多误解，包括其安全性和药物流产过程中的步骤。医疗服务提供者在消除这些神话和确保女性获得准确的信息以做出知情决定方面发挥着至关重要的作用。总之，米非司酮代表了生殖医疗的重大进步，为女性提供了一种安全有效的选择，以终止早期妊娠。随着围绕生殖权利的讨论不断演变，确保女性获得米非司酮及必要支持以应对她们的选择至关重要。通过促进理解和减少与该药物相关的污名，社会可以赋予女性掌控自身生殖健康的能力，并就自己的身体做出知情决策。最终，围绕米非司酮的讨论不仅仅是关于一种药物；它涉及女性权利、医疗保健获取和个人自主权等更广泛的问题。